News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

May 11, 2018 Katie Quinn

Biosimilars Forum Encouraged by Trump Administration’s Support for Biosimilars

March 9, 2018 Katie Quinn

Biosimilars Forum Encouraged By Food And Drug Administration Commissioner’s Support of Biosimilars

February 22, 2018 Katie Quinn

Biosimilars Forum Opposes Efforts to Prohibit Biosimilars From Receiving Pass-Through Payment Status

February 12, 2018 Katie Quinn

Biosimilars Forum Supports Inclusion of Biosimilars in the Medicare Coverage Gap Discount Program

November 2, 2017 Katie Quinn

Biosimilars Forum Applauds CMS Decision to Reverse Existing Rule on Biosimilar Reimbursement Policy

October 24, 2017 Katie Quinn

Biosimilars Forum Applauds Food and Drug Administration on New Educational Program Promoting Safety and Effectiveness of Biosimilars

September 14, 2017 Katie Quinn

Biosimilars Forum Opposes Current CMS Rule That Would Adversely Affect Biosimilars Development in the U.S.; Submits Comments on Appropriate Biosimilar Reimbursement Policy

August 19, 2017 Katie Quinn

Biosimilars Forum Applauds President Trump for Signing the FDA Reauthorization Act

August 3, 2017 Katie Quinn

Biosimilars Forum Applauds Senate Passage of the FDA Reauthorization Act

July 19, 2017 Katie Quinn

Biosimilars Forum Makes Available Xcenda Study on Budgetary Impact of Biosimilars Coding